Tectonic Therapeutic (TECX) Change in Account Payables (2017 - 2026)
Tectonic Therapeutic (TECX) reported Change in Account Payables of $1.4 million for Q1 2026, down 12.69% year-over-year from $1.6 million in Q1 2025, and up 503.21% quarter-over-quarter from -$343000.0 in Q4 2025.
Tectonic Therapeutic (TECX) Change in Account Payables (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Change in Account Payables data on file, last reported at $1.4 million in Q1 2026.
- Change in Account Payables for Q1 2026 came in at $1.4 million, down 12.69% year-over-year; the trailing twelve-month figure through Mar 2026 was -$85000.0 (up 93.69% YoY), and the FY2025 annual result was $116000.0, up 108.16% from the prior year.
- Change in Account Payables rose to $1.4 million in Q1 2026 per TECX's latest filing, from -$343000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $2.3 million in Q3 2023 and troughed at -$4.2 million in Q4 2023.
- A 5-year average of -$187588.2 and a median of $137000.0 in 2025 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2022 and 2025: Change in Account Payables jumped 2219.23% in 2022, then plunged 1567.44% in 2025.
- A 5-year view of Change in Account Payables shows it stood at -$1.4 million in 2022, then slumped by 192.59% to -$4.2 million in 2023, then soared by 65.65% to -$1.4 million in 2024, then soared by 76.13% to -$343000.0 in 2025, then soared by 503.21% to $1.4 million in 2026.
- Business Quant data shows TECX's Change in Account Payables at $1.4 million in Q1 2026, -$343000.0 in Q4 2025, and -$1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -9.42 Mn |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.38 Mn |
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | -343,000.00 |
| Dec 31, 2025 | -343,000.00 |
| Sep 30, 2025 | -1.26 Mn |
| Sep 30, 2025 | -1.26 Mn |
| Jun 30, 2025 | 137,000.00 |
| Jun 30, 2025 | 137,000.00 |
| Mar 31, 2025 | 1.58 Mn |
| Mar 31, 2025 | 1.58 Mn |
| Dec 31, 2024 | -1.44 Mn |
| Dec 31, 2024 | -1.44 Mn |
| Sep 30, 2024 | 86,000.00 |
| Sep 30, 2024 | 86,000.00 |
| Jun 30, 2024 | -1.58 Mn |
| Jun 30, 2024 | -1.58 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Dec 31, 2023 | -4.18 Mn |
| Dec 31, 2023 | -4.18 Mn |